The Oncology Institute (NASDAQ: TOI) has announced key financial developments, including an amendment to its facility agreement with Deerfield Management Company and a partial debt reduction. The amendment removes the $40 million minimum cash covenant and lifts restrictions on equity offerings. TOI has paid down approximately $20 million of senior secured convertible notes and related interest.
The company has also reported significant progress in its growth initiatives, having secured three new capitation agreements in 2025, adding roughly 80,000 lives across California, Nevada, and Florida markets. Notably, Florida operations now manage over 200,000 lives under value-based agreements, including more than 50,000 under Medicare Advantage.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.